Article metrics
PDF
Other content recommended for you
- Eculizumab versus rituximab in generalised myasthenia gravis
- Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
- Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis
- Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials
- Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
- Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study
- Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
- Rituximab in AChR subtype of myasthenia gravis: systematic review
- Update on myasthenia gravis
- Third distant recurrence of benign thymoma in a patient with myasthenia gravis